Answers are grounded in this paper and cite their sources.
Findings reveal that first-line treatment with daratumumab and dexamethasone predicts overall survival in transplant-ineligible myeloma patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: